HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabetta Ceni Selected Research

5-hydroxycytosine

9/2020Ligation-Mediated Polymerase Chain Reaction Detection of 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine and 5-Hydroxycytosine at the Codon 176 of the p53 Gene of Hepatitis C-Associated Hepatocellular Carcinoma Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabetta Ceni Research Topics

Disease

7Neoplasms (Cancer)
05/2022 - 02/2005
4Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 02/2005
4Hepatocellular Carcinoma (Hepatoma)
09/2020 - 08/2010
3Adenocarcinoma
05/2022 - 02/2005
3Adrenal Cortex Neoplasms (Adrenocortical Cancer)
03/2015 - 03/2005
3Adrenocortical Carcinoma
03/2015 - 03/2005
3Fibrosis (Cirrhosis)
02/2008 - 06/2002
3Liver Cirrhosis (Hepatic Cirrhosis)
02/2008 - 06/2002
2Carcinogenesis
12/2014 - 08/2010
2Alcoholic Liver Diseases (Alcoholic Liver Disease)
12/2014 - 10/2006
1Hepatitis C
09/2020
1Insulin Resistance
01/2020
1Hyperthermia
04/2017
1Hypoxia (Hypoxemia)
01/2017
1Breast Neoplasms (Breast Cancer)
08/2016
1Carcinoma (Carcinomatosis)
03/2015
1Liver Neoplasms (Liver Cancer)
11/2014
1Alcoholism (Alcohol Abuse)
02/2008
1Type 2 Diabetes Mellitus (MODY)
09/2006
1Thrombophilia
03/2006
1Liver Diseases (Liver Disease)
11/2002

Drug/Important Bio-Agent (IBA)

5ThiazolidinedionesIBA
08/2010 - 06/2002
3Orphan Nuclear ReceptorsIBA
05/2022 - 04/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2016 - 05/2005
3AcetaldehydeIBA
12/2014 - 10/2006
3Hypoglycemic Agents (Hypoglycemics)IBA
08/2010 - 02/2005
3PPAR gammaIBA
08/2010 - 06/2002
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2022 - 04/2014
2Transcription Factors (Transcription Factor)IBA
05/2022 - 08/2010
28-Hydroxy-2'-DeoxyguanosineIBA
09/2020 - 08/2016
2Codon (Codons)IBA
09/2020 - 08/2016
2DNA (Deoxyribonucleic Acid)IBA
04/2017 - 12/2014
2DNA AdductsIBA
08/2016 - 12/2014
2Proteins (Proteins, Gene)FDA Link
03/2015 - 03/2005
2Ethanol (Ethyl Alcohol)IBA
12/2014 - 02/2008
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2014 - 02/2011
2ProdrugsIBA
11/2014 - 02/2011
2ThymidineIBA
11/2014 - 02/2011
2acycloguanosyl 5'-thymidyltriphosphateIBA
11/2014 - 02/2011
2Acyclovir (Aciclovir)FDA LinkGeneric
11/2014 - 02/2011
2Biological ProductsIBA
08/2010 - 02/2008
2LigandsIBA
08/2010 - 06/2002
2Rosiglitazone (Avandia)FDA Link
01/2008 - 06/2002
2CollagenIBA
05/2005 - 06/2002
1Protein Isoforms (Isoforms)IBA
05/2022
15-hydroxycytosineIBA
09/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1ATPases Associated with Diverse Cellular ActivitiesIBA
01/2020
1NF-kappa B (NF-kB)IBA
01/2017
1NucleotidesIBA
08/2016
1EnzymesIBA
03/2015
1Small Interfering RNA (siRNA)IBA
04/2014
1GemcitabineFDA Link
02/2011
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2008
1Insulin (Novolin)FDA Link
09/2006
1HomocysteineIBA
03/2006
1Messenger RNA (mRNA)IBA
03/2005
1Therapeutic UsesIBA
02/2005
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2005
1Pharmaceutical PreparationsIBA
11/2002
1pirfenidoneIBA
11/2002
1Dimethylnitrosamine (Nitrosodimethylamine)IBA
06/2002
1Pioglitazone (Actos)FDA Link
06/2002
1Carbon Tetrachloride (Tetrachloromethane)IBA
06/2002

Therapy/Procedure

3Ligation
09/2020 - 06/2002
2Therapeutics
04/2014 - 11/2002
2Oral Administration
08/2010 - 06/2002